Updates

CSRXP APPLAUDS PRESIDENT BIDEN FOR TAKING MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE

Aug 16, 2022

Biden Administration and Congress Deliver Positive Progress on Longstanding Read More

BIG PHARMA WATCH: DRUG COMPANIES ON PACE FOR RECORD 2022 LAUNCH PRICES

Aug 16, 2022

Analysis Finds Brand Name Manufacturers Bringing New Drugs to Market with Read More

CSRXP: CONGRESS TAKES MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES FOR THE AMERICAN PEOPLE

Aug 12, 2022

Big Pharma Can No Longer Evade Accountability and Keep Prices High by Spending Read More

ICYMI: OPINION: DRUG COMPANIES ARE WARNING THAT PRICING REFORM SPELLS DOOM. DON’T FALL FOR IT

Aug 8, 2022

Washington Post Op-ed Debunks Bogus Big Pharma Claims That Solutions to Lower Read More

CSRXP APPLAUDS SENATE FOR MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE AND LOWERING PRESCRIPTION DRUG PRICES

Aug 7, 2022

Drug Pricing Solutions in Inflation Reduction Act of 2022 Will Help Crack Down Read More

BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA, AMGEN

Aug 5, 2022

Big Pharma Drugmakers Top Wall Street Estimates After Hiking Drug Prices Read More

SECOND OPINION: PHRMA’S LAST-DITCH ATTEMPT TO DERAIL SOLUTIONS TO LOWER DRUG PRICES REHASHES DEBUNKED ARGUMENTS

Aug 5, 2022

Pharmaceutical Industry Attempts to Intimidate Lawmakers and Keep Prices High Read More

ICYMI: CIVICASCRIPT BRINGS FIRST GENERIC DRUG TO MARKET TO PROVIDE MORE AFFORDABLE ALTERNATIVE TO HIGH-PRICED BIG PHARMA PRODUCTS

Aug 3, 2022

Private Sector and Non-Profit Partners Introduce Cancer Treatment That Can Read More

BIG PHARMA EARNINGS WATCH: PFIZER, MERCK, BRISTOL MYERS SQUIBB, GLAXOSMITHKLINE AND SANOFI

Jul 29, 2022

Big Pharma Giants All Top Analysts’ Expectations as Pharmaceutical Industry Read More

CSRXP COMMENDS ADVANCEMENT OF BILL TO BOOST AGENCY COOPERATION TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

Jul 28, 2022

Bipartisan Interagency Patent Coordination and Improvement Act of 2022 Will Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, ROCHE, NOVARTIS

Jul 22, 2022

Big Pharma Kicks Off Q2 Earnings Calls After More than 100 Price Hikes to Read More